ArticleEndocrine2021

Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience.

Camilla Bardasi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.